Does Nintedanib Benefit Certain Subgroups of IPF Patients More than Others? An Analysis of the Data from the INPULSIS Trials - a podcast by American Thoracic Society
from 2016-01-15T10:03
::
::
Dr. Nitin Seam talks with Drs. Ulrich Costabel and Athol Wells about idiopathic pulmonary fibrosis and which patients may benefit from nintedanib treatment. They discuss the INPULSIS trials and Dr. Costabel's article in the January 15 issue of AJRCCM.
Further episodes of Out of the Blue: An AJRCCM Podcast
Further podcasts by American Thoracic Society
Website of American Thoracic Society